4
Clinical Trials associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)The Safety and Immunogenicity of 10μg/0.5ml Recombinant Hepatitis B Vaccines(Saccharomyces Cerevisiae) in the Healthy Neonates
The purpose of this study is to further evaluate the immunogenicity and safety of 10μg/0.5ml Recombinant Hepatitis B Vaccines(Saccharomyces Cerevisiae) in the Healthy Neonates.
新生儿接种10μg/0.5ml规格重组乙型肝炎疫苗(酿酒酵母)的安全性和有效性研究
[Translation] Safety and efficacy of 10 μg/0.5 ml recombinant hepatitis B vaccine (Saccharomyces cerevisiae) in neonates
观察新生儿接种10μg/0.5ml规格重组乙型肝炎疫苗(酿酒酵母)的安全性,了解新生儿接种10μg/0.5ml规格重组乙型肝炎疫苗(酿酒酵母)的免疫持久性。
[Translation] To observe the safety of neonatal vaccination with 10μg/0.5ml recombinant hepatitis B vaccine (Saccharomyces cerevisiae) and to understand the immune persistence of neonatal vaccination with 10μg/0.5ml recombinant hepatitis B vaccine (Saccharomyces cerevisiae).
对16岁及16岁以上健康人群进行的20μg重组乙型肝炎疫苗(酿酒酵母)单中心Ⅳ期临床试验
[Translation] A single-center phase IV clinical trial of 20 μg recombinant hepatitis B vaccine (Saccharomyces cerevisiae) in healthy people aged 16 years and above
验证深圳康泰生物制品股份有限公司生产的20μg重组乙型肝炎疫苗(酿酒酵母)在16岁及16岁以上常住健康人群中的安全性和免疫原性。
[Translation] To verify the safety and immunogenicity of 20μg recombinant hepatitis B vaccine (Saccharomyces cerevisiae) produced by Shenzhen Kangtai Biological Products Co., Ltd. in healthy residents aged 16 years and above.
100 Clinical Results associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)
100 Translational Medicine associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)
100 Patents (Medical) associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)
100 Deals associated with Recombinant hepatitis B vaccine(Shenzhen Kangtai Biological Products Co., Ltd.)